Spring 2010

Spring 2010

Cancer Center Seminar Series

Spring 2010

 

Fridays 12:30-1:30pm
McKim Hall Auditorium, unless otherwise noted

The UVA Cancer Center presents this seminar series.  Refreshments will be served outside McKim Auditorium beginning at 12:00.

Please note, the Seminar Series is not being offered for CME credit.

January   February   March   April   May   June


Date
Speaker and Title
Host
Location


1/15/10 
Margaret A. Shupnik, PhD
Professor of Medicine & Physiology, Associate Dean for Basic Research

Estrogen Receptor Signaling Networks in Breast Cancer - Sculpting Responses to Endocrine Therapies
Sally Parsons, PhD  
McKim Auditorium

1/22/10 BJ Purow, MD
Department of Neurology

Jason Boyd, MD
Fellow, Division of Hematology/Oncology

MicroRNAs Interacting with Key Cancer Pathways
Sally Parsons, PhD McKim Auditorium

2/5/10 Canceled due to weather, rescheduled for April 16th
 

2/12/10 E. Antonio Chiocca, MD, PhD
Chairman of Department of Neurological Surgery, Dardinger Family Professor of Oncologic Neurosurgery, Co-director, Dardinger Center for Neuro-oncology and Neurosciences, James Cancer Hospital/Solove Research Institute, The Ohio State University Medical Center

Translational Therapies for Gliomas
Roger Abounader, MD, PhD McKim Auditorium

2/19/10 Brian G. Rowan, PhD
Associate Professor, Structural & Cellular Biology, Tulane Medical School

Novel Src Kinase Inhibitor Directed Towards the Peptide Substrate Site Synergizes with Tamoxifen and Chemotherapy in Breast Cancer
Peggy Shupnik, PhD McKim Auditorium

2/26/10
William Knaus, MD
Department of Public Health Sciences

Advancing Genomics and Personalized Cancer Care for Patients and Populations using Electronic Medical Records
Sally Parsons, PhD McKim Auditorium

3/5/10 Adrian U. Wiestner, MD, PhD
Principal Investigator, Hematology Branch, National Heart, Lung, and Blood Institute, NIH

Translational Studies into Pathogenesis and
Treatment of Lymphoid Malignancies

Ronald Taylor, PhD McKim Auditorium

3/12/10 Dean Kedes, MD, PhD
Department of Medicine, Infectious Diseases and

Matt Quesenberry, MD
Fellow, Division of Hematology/Oncology

Going Viral, “A Gangster Story”
Sally Parsons, PhD McKim Auditorium

3/19/10 Daniel G. Jay, PhD
Professor of Physiology, Tufts University

Functional Proteomic Screens for Proteins Required for Cancer Invasiveness
Paul Yates, MD, PhD
McKim Auditorium

3/26/10 Clive S. Zent, MD
Associate Professor of Medicine, Division of Hematology, Mayo Clinic

CLL 2010: Progress and Challenges
Ronald Taylor, PhD McKim Auditorium

4/2/10
Dee Eadie, MSW, MSN
Associate Director, Clinical Administration

Christi Sheffield
Manager, Comprehensive Cancer Control Program

Nila Saliba
Cancer Control/Outreach

Opportunities in Cancer Prevention, Early Detection, and Control
Sally Parsons, PhD McKim Auditorium

4/9/10 Oliver Bogler, PhD
Associate Professor & Director of Basic Science, Brain Tumor Center, Depts. of Neurosurgery and Neuro-Oncology, MD Anderson Cancer Center

Analysis of Aberrant EGFR Signaling in Gliomas with Mass Spectometry-based Phosphoproteomics
Roger Abounader, MD, PhD McKim Auditorium

4/16/10
Victor H. Engelhard, PhD
Department of Microbiology

New Antigens and New Strategies to Enhance Immunological Control of Melanoma and Other Cancers
Sally Parsons, PhD McKim Auditorium

4/16/10 3:00-4:00pm, Microbiology Library, Jordan Hall 7006
Karen R. McLachlan, PhD
Associate Director, Translational Oncobiology Biogen Idec, Inc.

The Role of Integrins in Tumor Progression and as Therapeutic Targets
Jill Slack-Davis, PhD
Jordan Hall 7006

4/22/10
Thursday, Jordan Hall 1-17
Benjamin F. Cravatt III, PhD
Professor and Chair, Department of Chemical Physiology,The Skaggs Institute for Chemical Biology, Helen L. Dorris Child and Adolescent Neuro-Psychiatric Disorder Institute, The Scripps Research Institute, The Scripps Research Institute

Activity-based Proteomics: Applications for Enzyme and Inhibitor Discovery
Kevin Lynch, PhD
Jordan Hall 1-17

4/30/10 David H. Gutmann, MD, PhD
Donald O. Schnuck Family Professor of Neurology, Co-director, Neuro-Oncology Program, Director, Neurofibromatosis Center, Washington University/Alvin J. Siteman Cancer Center

Deconstructing Brain Tumors: It Takes a Village
Roger Abounader, MD, PhD McKim Auditorium

5/7/10 Gary K. Owens, PhD
Professor of Molecular Physics and Biological Physics, Director, Robert M. Berne Cardiovascular Research Center

Identification and Characterization of the Functional Effects of Novel Human Retroviruses Implicated in the Pathogenesis of Familial Prostate Cancer
David Brautigan, PhD McKim Auditorium

5/14/10 Amy Bouton, PhD
Department of Microbiology

Mel Lu, MD
Fellow, Division of Hematology/Oncology

The Role of Macrophages in Breast Cancer Progression and Development of Novel Targets
Sally Parsons, PhD McKim Auditorium

5/21/10 John A. Cidlowski, PhD
Principal Investigator, Molecular Endocrinology Group, National Institute of Environmental Health Sciences, National Institutes of Health

Glucocorticoid Receptors in Health and Disease
Dan Gioeli, PhD McKim Auditorium

5/28/10 Maura L. Gillison, MD, PhD
Professor of Internal Medicine & Epidemiology, Coughlin Chair of Cancer Research, Ohio State University

HPV and a Paradigm Shift in Concepts of Risk for Head and Neck Cancer
Paul Read, MD, PhD McKim Auditorium

6/4/10 Kevin A. Camphausen, MD
Head, Imaging and Molecular Therapeutics Section, Branch Chief, Radiation Oncology Branch, National Cancer Institute, NIH

Pre-Clinical Models in Radiation Oncology
BJ Purow, MD McKim Auditorium

6/11/10

Janet Cross, PhD
Department of Pathology, Research

Jeanna Knoble, MD
Fellow, Division of Hematology/Oncology

Two Perspectives on Cancer Chemoprevention

Sally Parsons, PhD McKim Auditorium

Back to Top Seminar Series Home